Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DR-3355 injection vs pazufloxacin injection in urinary tract infection
jRCT2080221777Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in urinary tract infection (UTI), pyelonephritis and cystitis comparing Levofloxacin (DR-3355) injection with Pazufloxacin injection (2 arms).
02
Drugs
levofloxacinpazufloxacin
03
Conditions
urinary tract infection (UTI)pyelonephritiscystitis
Beyond the preview
Go deeper on jRCT2080221777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221777.